Porvair Filtration Group Display Sintered Porous Materials for Medical Applications at Medica / CompaMed 2013

24 Oct 2013
Sonia Nicholas
Managing Editor and Clinical Lead

Product news

Porvair Filtration Group, an international leader in high performance filtration and separation materials and products for the medical, pharmaceutical and life science industries will be exhibiting at the Medica / CompaMed 2013 trade show in Düsseldorf.

On Stand F-08 in Hall 8a, Porvair will showcase regulatory approved BioVyon™ sintered porous plastic materials and its flagship product, Chromatrap®, based upon proprietary BioVyon™ technology and used by researchers to identify cancer biomarkers.

BioVyon™ porous materials are used for in vitro filtration, separation, venting and wicking applications in the medical, pharmaceutical and life science industries. Through a combination of new material developments, including composites and surface modified structures, and working in partnership with OEM and end user customers, Porvair is able to achieve optimum design and regulatory approval. Recent developments have included nasal spray filters, drug delivery filters and catheter vents. Manufactured in ISO-accredited cleanrooms, BioVyon™ materials exhibit very low particle shedding, low extractables and low bioburden, making them ideally suited to critical applications.

The Chromatrap® product, a novel chromatin immunoprecipitation (ChIP) assay, utilises BioVyon™ material to which Protein A or Protein G has been chemically bound. The Chromatrap® solid phase porous structure captures antibody-tagged DNA-protein complexes associated with cancers. This technology is paving the way in the quest for targeted cancer treatments and personalised medicines.

To discuss your application please visit our stand at Medica /CompaMed in Hall 8a (Stand F-08) or click on the ‘request information’ link below.

Links

Tags

Medicinal ChemistryMedicinal chemistry is a broad discipline encompassing the design, identification, synthesis and development of chemicals in drug discovery. It includes a number of techniques covering structural biology, synthetic chemistry and molecular biology. Technologies used in medicinal chemistry include ADME, lab-on-a-chip, high content screening and assay assembly.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.MEDICA
Porvair Filtration Group Display Sintered Porous Materials for Medical Applications at Medica / CompaMed 2013